Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark T. Osterman
Vedolizumab Exposure Levels and Clinical Outcomes in Ulcerative Colitis: Determining the Potential for Dose Optimisation
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Vedolizumab Exposure in Pregnancy: Outcomes From Clinical Studies in Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Serum Complement Levels in Active Ulcerative Colitis
Gut
Gastroenterology
Vedolizumab in Ulcerative Colitis; A Budget Impact Model for a Novel Drug in a Recession Environment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Baseline Levels of Dynamic CD4+ T Cell Adhesion to MAdCAM-1 Correlate With Clinical Response to Vedolizumab Treatment in Ulcerative Colitis: A Cohort Study
BMC Gastroenterology
Medicine
Gastroenterology
Clinical Study of the Relation Between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Letter: Dose Optimising Infliximab in Acute Severe Ulcerative Colitis
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Activity-Based Costing and Budget Analysis of Vedolizumab Versus Conventional Treatments in Ulcerative Colitis and Crohn’s Disease
Global and Regional Health Technology Assessment
Health Policy
